person · Reporting owner

Emerson Martin J

Disclosed activity across 2 companies

Tapewire entity: 50850
SEC CIK: 0001230453

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Nuwellis, Inc.NUWE · Entity 8478	Director	April 28, 2026	April 29, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Nuwellis, Inc.

Report date April 28, 2026 · Filed April 29, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Nonstatutory Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.16 · Expires 2036-04-27	Direct	6,744	Reported balance After 2026-04-28 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-04-28 · Grant · Acquired 6,744 · Balance 6,744 F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.

Filing footnotes · ownership attribution and instrument terms

F1: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

VASCULAR SOLUTIONS INC

Report date February 17, 2017 · Filed February 22, 2017

Section 16 reporting ended · disclosed 2017-02-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2017-02-17 transaction · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · 2017-02-17 · Disposition to issuer · Disposed 8,435 · Balance 0 F1: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.
Common StockSEC Table I · non-derivative	Direct	8,435	Reported balance Holding disclosure · report date 2017-02-17 · row 1 Holding and transaction disclosures are not merged. 1 source row Row 1 · Balance 8,435
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.63 · Expires 2022-05-04	Direct	0	Reported balance After 2017-02-17 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2017-02-17 · Disposition to issuer · Acquired 10,000 · Balance 0 F2: This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $443,700, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes.

F2: This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $443,700, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
April 28, 2026 Filed Apr 29, 2026 21:16 UTC	Nuwellis, Inc. NUWE · Entity 8478	GrantNonstatutory Stock Option (right to buy) · Derivative	6,744	$0.00 Strike: $1.16	$0.00	Disclosure SEC source: 0001140361-26-017870 · form4.xml · derivative · entry 1 Emerson Martin J · CIK 0001230453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,744 Underlying: Common Stock · 6,744 shares Expires 2036-04-27 F1 · derivative.exercise_date: Vests in 12 approximately equal consecutive monthly increments, commencing on the one-month anniversary of the date of grant, so that all of the options will be vested on the one-year anniversary of the date of grant. Read SEC document
February 17, 2017 Filed Feb 22, 2017 16:22 UTC	VASCULAR SOLUTIONS INC VASC · Entity 178639	Disposition to issuerStock Option (Right to Buy) · Derivative	10,000	$44.37 Strike: $11.63	$443,700.00	Disclosure SEC source: 0001140361-17-008595 · doc1.xml · derivative · entry 3 Emerson Martin J · CIK 0001230453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-05-04 F2 · derivative.exercise_date: This option, which is fully vested, was canceled pursuant to the Merger in exchange for a cash payment of $443,700, representing the difference between the exercise price of the option and the merger consideration per share ($56.00) multiplied by the total number of shares underlying the option, less any applicable withholding taxes. Read SEC document
February 17, 2017 Filed Feb 22, 2017 16:22 UTC	VASCULAR SOLUTIONS INC VASC · Entity 178639	Disposition to issuerCommon Stock	8,435	Not disclosed	Not disclosed	Disclosure SEC source: 0001140361-17-008595 · doc1.xml · nonDerivative · entry 2 Emerson Martin J · CIK 0001230453 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: In connection with the merger of Issuer and a subsidiary of Teleflex Incorporated (the "Merger") pursuant to an agreement and plan of merger dated December 1, 2016, all shares of Issuer common stock were canceled and automatically converted into the right to receive $56.00 per share in cash, without interest and less any applicable withholding taxes. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.